ENASS, A. ABDEL-HAMEED

University of Cincinnati

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Kenneth E. Sherman

University of Cincinnati College of Medicine

UNITED STATES

View details

Mohamed Tarek Shata

Associate Prof

University of Cincinnati

UNITED STATES

View details

Jacqueline Hernandez

Florida International University

UNITED STATES

View details

Sabrina Sales Martinez

Assistant Professor

Florida International University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

ENASS, A. ABDEL-HAMEED

Research Interests

Explore related searches

Contact this professor

Articles (6)

Humoral and T-cell-mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients.

Humoral and T-cell–mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients

Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis

Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons.

The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients.

Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index

Collaborators (4)

Kenneth E. Sherman

Mohamed Tarek Shata

Jacqueline Hernandez

Sabrina Sales Martinez

Make your next move.

ENASS, A. ABDEL-HAMEED

Research Interests

Explore related searches

Contact this professor

Articles (6)

Humoral and T-cell-mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients.

Humoral and T-cell–mediated immunity to SARS-CoV-2 vaccination in patients with liver disease and transplant recipients

Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation &amp; Fibrosis

Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons.

The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients.

Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index

Collaborators (4)

Kenneth E. Sherman

Mohamed Tarek Shata

Jacqueline Hernandez

Sabrina Sales Martinez

Make your next move.

Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis